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ABSTRACT
Gene knockout strategies, RNAi and rescue exper-
iments are all employed to study mammalian gene
function. However, the disadvantages of these ap-
proaches include: loss of function adaptation, re-
duced viability and gene overexpression that rarely
matches endogenous levels. Here, we developed an
endogenous gene knockdown/rescue strategy that
combines RNAi selectivity with a highly efficient
CRISPR directed recombinant Adeno-Associated
Virus (rAAV) mediated gene targeting approach to
introduce allele-specific mutations plus an allele-
selective siRNA Sensitive (siSN) site that allows
for studying gene mutations while maintaining en-
dogenous expression and regulation of the gene
of interest. CRISPR/Cas9 plus rAAV targeted gene-
replacement and introduction of allele-specific RNAi
sensitivity mutations in the CDK2 and CDK1 genes
resulted in a >85% site-specific recombination of
Neo-resistant clones versus ∼8% for rAAV alone.
RNAi knockdown of wild type (WT) Cdk2 with siWT
in heterozygotic knockin cells resulted in the mutant
Cdk2 phenotype cell cycle arrest, whereas allele spe-
cific knockdown of mutant CDK2 with siSN resulted
in a wild type phenotype. Together, these observa-
tions demonstrate the ability of CRISPR plus rAAV to
efficiently recombine a genomic locus and tag it with
a selective siRNA sequence that allows for allele-
selective phenotypic assays of the gene of interest
while it remains expressed and regulated under en-
dogenous control mechanisms.
INTRODUCTION
The classical way to study mammalian gene function is to
genetically knockout the gene or RNAi deplete the mRNA
and hence, the protein of interest, to induce a phenotype. To
confirm that the targeted gene was the causal gene requires
rescuing the loss of function phenotype by ectopic expres-
sion of a variant of the same gene. Unfortunately, constitu-
tive gene knockout can activate compensatory mechanisms
that significantly impair the phenotype and conclusions to
gene function (1,2). In contrast, acute RNAi-mediated gene
depletion can reveal additional functions and lead to amore
detailed molecular understanding (3). However, rescue of
either gene deletion or depletion is equally fraught with
potential pitfalls. Commonly used protein expression sys-
tems, including stably integrated genomic constructs under
inducible promoters (4), often significantly overexpress the
rescue protein, which alters the stoichiometry of protein–
protein interactions and can lead to potential false-positive
‘rescue’ results (5,6). While the lack of proper gene regula-
tion can potentially be addressed using minigenes or bacte-
rial artificial chromosomes (6), these approaches represent
an artificial situation for the cell. To close this gap, we de-
veloped a gene knockdown/rescue strategy that works at
the endogenous gene level by combining RNAi selectivity
with a highly efficient CRISPR–Cas (7–10) directed recom-
binant Adeno-Associated Virus (rAAV) mediated gene tar-
geting approach to introduce allele-specific phenotypic mu-
tations of interest plus an allele-selective siRNA Sensitive
(siSN) site (Figure 1).
MATERIALS AND METHODS
CRISPR and rAAV cloning procedures
Cdk2- and Cdk1-specific gRNAs were designed that
contain unique sequence between exons 3 and 4 and cloned
into pX330 (11). Cdk2 gRNA: 5′-tcattatattcattaaccct-3′
and Cdk1 gRNA: 5′-aatttgtaatttaaggatcg-3′. For in-
frame cloning of human Cdk2 genomic locus, DNA
oligonucleotides 5′-ttgtacagctcgtccatgccgag-3′ and
5′-tcagagtcgaagatggggtactggc-3′ were used. To gen-
erate plasmids refractory to Cdk2 siWT siRNA
duplexes, a series of seven silent point-mutations
was introduced using the DNA oligonucleotide 5′-
atctctctgcttaaggaattgaatcacccgaacattgtcaagctgct-3′
and its corresponding antisense. Left and right ho-
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Figure 1. CRISPR/Cas9 plus rAAV targeted recombination. (A) Study concept of combining CRISPR/Cas9 plasmid co-expressing a specific guide strand
with rAAV. (B) Design of rAAV Cdk2 promoter-less construct. (C) Graphic depiction of the rAAV-targeting strategy to introduce siSN silent point-
mutations into exon 2 and a point mutation at Thr-160 to Ala (T160A) of human Cdk2. Highlighted are the two crucial steps of ‘targeting’ (Cas9 + gRNA
+ ssDNA) and allele ‘restoration’ (+Cre). Note locations of gRNA, siSN and T160A. (D) Introduction of siSN sequence plus a gene mutation into one
allele of a given gene allows for selective depletion of the wild type allele by siWT resulting in a mutant phenotype, selective depletion of the mutant gene
by siSN resulting in a rescued phenotype or depletion of both alleles to mimic a loss of function phenotype.
mology arms required to target the human Cdk2
locus were generated using genomic DNA of hTERT-
RPE1 cells and the following DNA oligonucleotides:
LHA-f 5′-ggagaggtgggttgggggccagtagaagg-3′ LHA-r 5′-g
cagggaaggagacacaaaaagaagggg-3′, RHA-f 5′-ccctagggttg
gactgaacaatcaaagttg-3′ and RHA-r 5′-gtttccttccctccatcat
ctttcccctccc-3′. To introduce siWT refractory mutations
into the left homology arm the DNA oligonucleotides
5′-atctctctgcttaaggaattgaatcacccgaacattgtcaagtaagta-3′ an
d 5′-tacttacttgacaatgttcgggtgattcaattccttaagcagagagat-3′
were used. Left and right homology arms were cloned
into pAAV-SEPT (12). Infectious rAAV particles were
generated by transfection of 293T cells with 3 g of donor
template containing pAAV-SEPT, and packaging plasmids
pAAV-RC and pHELPER. Transfected 293T cells were
incubated for 5 days, prior to harvest of cells, followed by
four freeze/thaw cycles to release infectious rAAV particles.
Cellular debris was separated by centrifugation and rAAV
containing supernatant was stored at −80◦C.
Clonal selection of recombined clones
hTERT-RPE1 cells were seeded to a density of 30% (∼2
× 105 cells) in a 10-cm dish and incubated overnight. Cells
were washed with phosphate-buffered saline (PBS) and in-
cubated 30 min with 5 ml of serum-free Dulbecco’s Mod-
ified Eagle (DME)/F12 media (Life Technologies) before
5 ug of ethanol-precipitated gRNA/Cas9-plasmid (pX330)
was transfected. After 4 h, cells were washed with fresh
DME/F12 media and incubated for an additional 2 h. To
transduce cells with rAAV, cells were washed twice with
10 ml Hank’s Balanced Salt Solution (HBSS) buffer. Six
milliliters of processed rAAV-containing supernatant was
mixed with 3 ml of fresh DME/F12 media and added on to
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cells (13). After 4 h of incubation, an additional 6 ml (15 ml
total) of fresh DME/F12 media was added to cells and in-
cubated for 48 h. To start the clonal selection of recombined
clones, cells were trypsinized and collected in 20 ml of fresh
DME/F12 media supplemented with 400 ug/mL G418.
Cells were seeded into 96-well plates, wrapped in plastic to
prevent evaporation and incubated for 3 weeks. Wells with
multiple colonies were deselected and monoclonal colonies
were processed. To remove the inserted floxed SA-IRES-
Neo cassette, cells were washed twice with HBSS buffer,
given fresh serum-free Dulbecco’s modified Eagle’s medium
(DMEM)/F12media and transduced with Adenovirus-Cre
(University of Iowa) for 12 h, followed bymedia supplemen-
tation with 10% serum.
PCR-based identification of recombined clones
Cells were grown in a 48-well format, split and 90% of cells
were used to extract genomic deoxyribonucleic acid (DNA)
with Total Nucleic Acid (TNA) buffer (0.1 M NaCl, 10
mM Tris–HCl pH 8, 1 mM ethylenediaminetetraacetic
acid (EDTA) and 10% sodium dodecyl sulfate (SDS))
and phenol:chloroform:isoamyl alcohol 25:24:1. Genomic
DNA was precipitated with 3 M Sodium Acetate (NaAc)
and 100% Ethanol (EtOH), washed with 75% EtOH and
resuspended in water. To identify correct recombined Cdk2
clones, a 10 ul polymerase chain reaction (PCR) reaction
with primer pairs P1 and P2 (Supplementary Figure S2A)
was performed on Cdk2 using OneTaq R© DNA Polymerase
(NEB), P1: 5′-atggagaacttccaaaaggtggaaaagatcgg-3′,
P2: 5′-ggatccactagttctagagagctcgcaggg-3′. To distinguish
between single allele and double Cdk2 allele recombined
clones, a second PCR using primers P3 and P4 was per-
formed using primer sequences P3: 5′-ccaagTGAGAC
TGAGGGTGTGCCCAGTACTGCCATCCG-3′, P4:
5′-ccagagaggataaggaccaagtcttactcaattttccatccc-3′.






AGGTGTGTTCAATGC-3′, and P4: 5′-GGCCATTTT
AGGCTAATAAGCATTTGTGGGTGGGAAGCCC-3′.
Allele-specific quantitative real-time PCR
hTERT-RPE1 cells were treated as described above. RNA
was extracted using RNeasy kit (Qiagen, Valencia, CA,
USA) and reversed transcribed using iSCRIPT cDNA syn-
thesis kit (Invitrogen). cDNAs were assayed on a ABI7300
thermal cycler using the SYBR select PCRmaster-mix (Ap-
plied Biosystems). Each sample was measured in tripli-
cates and the experiments have been repeated at least three
times. Relative gene expression normalized to GAPDH
was determined using the ddCt algorithm. Primers used
were: hCdk2-WT, forward, 5′-GAGCTTAACCATCCT
AATATTGTC-3′, reverse, 5′-GCTGGAACAGATAGC
TCTTGA-3′; hCdk2-Mut, forward, 5′-GAATTGAATCA
CCCGAACATTGTC-3′, reverse 5′-GCTGGAACAGA
TAGCTCTTGA-3′. hGAPDH, forward, 5′-GGAGTCA
ACGGATTTGGTCGTA-3′, reverse 5′-GGCAACAAT
ATCCACTTTACCA-3′.
Cell culture and synchronization
Human hTERT-RPE1 cells were cultured at 37◦C, in 5%
CO2 atmosphere in DME/F12 media (Life Technologies),
supplemented with 10% heat-inactivated fetal bovine serum
(FBS) and penicillin/streptomycin (100 and 100 g/ml, re-
spectively). Thymidine was obtained from Sigma–Aldrich.
For thymidine synchronization, cells were treated with 2
mM thymidine for 24 h prior to cell lysis. For cell cycle exit
synchronization, cells were thymidine synchronized and re-
leased by PBS wash and subsequently cultured in serum-
free DME/F12 media for 60 h. Cell cycle re-entry was ob-
tained by removal of serum-free media and addition of
DME/F12 media containing 10% heat-inactivated FBS.
Cell extracts and immunoprecipitation
Preparation of lysates and immunoblot analyses were
performed as described previously (5) using Tris lysis
buffer (50 mM Tris–HCl pH 7.8, 150 mM NaCl, 1%
IGEPAL CA-630) containing 20 mM NaF, 20 mM -
glycerophosphate, 0.3 mM Na-vanadate, 20 g/ml RNase
A, 20 g/ml DNase and 1/300 protease inhibitor cocktail
(P8340, Sigma–Aldrich) and phosphatase inhibitor cock-
tail #2 (P5726, Sigma–Aldrich). Antibodies used in this
study were purchased from the following sources: rabbit
anti-Cdk2 (M2 SC-163, Santa Cruz Biotechnology), mouse
anti-actin (ab-3280, Abcam, Cambridge, MA, USA), rab-
bit anti-GFP (ab-290, Abcam), mouse anti-tubulin (Devel-
opmental Studies Hybridoma Bank, University of Iowa),
mouse anti-Cyclin A (SC-751, Santa Cruz Biotechnology)
and mouse anti-cyclin E (SC-198, Santa Cruz Biotechnol-
ogy). Secondary antibodies used for western blot analysis
were goat anti-mouse (31430) and, goat anti-rabbit (31460,
Thermo Scientific). Mouse anti-tubulin hybridoma cell line
(clone #12G10) was developed by J. Frankel and E.M. Nel-
son under the auspices of the NICHD and maintained by
the Developmental Studies Hybridoma Bank.
Fluorescence microscopy
Cells were seeded and grown on coverslips, treated as in-
dicated, and simultaneously fixed and permeabilized for 10
min at RT with 4% PFA and 0.1% Triton-X100 in PBS. Im-
ages were acquired using a DeltaVision Olympus IX71 mi-
croscope equipped with a×60/1.42 oil objective. Collection
and processing of acquired imageswas carried out using Im-
ageJ 1.44o (Wayne Rasband, National Institutes of Health,
USA).
Size-exclusion chromatography (SEC)
Asynchronously growing cells were lysed in freshly prepared
SEC lysis buffer: 20 mM Tris–HCl, pH 7.4, 150 mMNaCl,
0.5% IGEPAL (CA-630), 1 mM DTT, 20 mM NaF, 20
mM betaglycerophosphate, 20 g/ml RNase A, 20 g/ml
DNase, 1 g/ul leupeptin, 1 g/ul aprotinin, 1/300 pro-
tease inhibitor cocktail (P8340, Sigma–Aldrich) and 1/100
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phosphatse inhibitor cocktail #2 (P5726, Sigma–Aldrich).
One milligram of total protein was loaded onto a Superdex
200 10/300 GL column (GE Healthcare Bio-Sciences) con-
nected to a BioLogicTM Low-Pressure Chromatography
Systems (Bio-Rad). A constant flow rate of 0.4ml/min of an
isocratic elution buffer (20 mMTris–HCL, pH 7.4, 150 mM
NaCl) was used and 500 l fractions were collected after an
initial retention volume of 16 ml. Fractions were TCA pre-
cipitated and resuspended in 50 l 2× Laemmli buffer for
SDS-page gel electrophoresis and immunoblotting.
Transient plasmid and siRNA transfection
Plasmid transfection was performed using Lipofectamin
2000 (Life Technologies) according to the manufacturer’s
instructions. siRNA duplexes were transfected using Lipo-
fectamin RNAiMAX (Life Technologies) according to
the manufacturer’s instructions. The following siRNA du-
plexes were synthesized and used: siCTRL passenger 5′-C
UUACGCUGAGUACUUCGAUT-3′, siWT passenger
5′-GAGCUUAACCAUCCUAAUATT-3′, and siSN pas-
senger 5′-GAAUUGAAUCACCCGAACATT-3′. siRNA
oligonucleotides were used at a final concentration of 25
nM. Plasmid transfections were performed for 48 h with
cells synchronized with thymidine. siRNA transfections
were done as indicated or performed for 36 h with cells syn-
chronized with thymidine.
Time-lapse video microscopy
hTERT-RPE1 cells stably expressing histone 2B-GFP were
seeded in six-well chambers, treated as indicated and im-
aged using a Nikon ECLIPSE Ti microscope equipped with
a CoolLED pE-1 excitation system and a×20/0.75 air Plan
Apo objective (Nikon). Images were acquired at multiple
positions every 20 min. To collect and process data, Im-
ageJ 1.44o software (Wayne Rasband, National Institutes
of Health, USA) was used, respectively.
RESULTS
rAAV mediated gene targeting by homologous recombina-
tion is a precise and powerful technique that is widely used
to study mammalian gene function (14–16). Although ss-
DNA rAAV mediated recombination is significantly more
efficient than recombination by dsDNA vectors, rAAV me-
diated gene targeting remains relatively inefficient. To ad-
dress this problem, we developed a CRISPR directed rAAV
gene-targeting strategy that uses the DNA cleavage selectiv-
ity of CRISPR/Cas9 to dramatically enhance the rAAV ss-
DNA mediated recombination frequency while also build-
ing in an allele-selective siSN site (Figure 1A). First, we
cloned the human Cdk2 genomic region from exons 2 to 4
into the pAAV-SEPT plasmid (Figure 1B) (12). To generate
the Cdk2 siSN allele, we introduced seven silent point mu-
tations into exon 2 sequence of Cdk2 (Cdk2-SN) (Supple-
mentary Figure S1A and B). We placed a floxed, in-frame
splice acceptor site (SA) and internal ribosome entry site
(IRES) cassette followed by a Neomycin resistance (NeoR)
gene between exons 3 and 4 (Figure 1B). This promoter-
less approach requires recombination into the Cdk2 locus
to obtain NeoR expression (Figure 1C). To test the speci-
ficity of siSN, we co-transfected both wild type (siWT) and
siSN siRNAs together with plasmids encoding either GFP-
Cdk2WT or GFP-Cdk2SN and analyzed for GFP-Cdk2 ex-
pression by immunofluorescence and immunoblotting. Im-
pressively, siWT specifically knocked down GFP-Cdk2WT
expression, while siSN restrictively knocked down only the
GFP-Cdk2SN construct (Supplementary Figure S1C and
D).
Based on locus and integration specific PCR assays, in-
fection of RPE cells with only Cdk2-SN-NeoR rAAV (no
CRIPSR) resulted in 2/26 (<8%) NeoR colonies containing
recombined Cdk2-SN single alleles, and no double alleles
(Figure 2A) (Supplementary Figure S2A, B and E). In con-
trast, infection of Cdk2-SN-NeoR rAAV plus transfection
of pX330 CRISPR/Cas9 plasmid co-expressing a Cdk2
guide strand RNA (gCdk2) that targets a unique sequence
between exons 3 and 4 resulted in an impressive 41/48 (85%)
NeoR colonies containing recombinedCdk2-SN (Figure 2B
and C) (Supplementary Figure S2D). We confirmed these
observations by locus-specific genomic sequencing (Fig-
ure 2D). Of the 41 Cdk2-SN colonies, 38 (93%) were single
Cdk2-SN alleles (Cdk2+/SN) and 3 (7%) were double alleles
(Cdk2SN/SN) (Supplementary Figure S2G).
Insertion of the SA-IRES-NeoR cassette between ex-
ons 3 and 4 of Cdk2 (Cdk2+/SN-NeoR) temporarily inacti-
vates the targeted Cdk2 allele and resulted in a 50% re-
duction of Cdk2 compared to parental Cdk2+/+ cells (Sup-
plementary Figure S3A). However, the cell cycle profile of
Cdk2+/SN-NeoR clones were indistinguishable from parental
cells (Supplementary Figure S3B). Consistent with this ob-
servation, size-exclusion chromatography from lysates of
asynchronously cycling Cdk2+/+ and Cdk2+/SN-NeoR clones
showed no significant differences between complexes of
Cdk2 with cyclins E and A (Supplementary Figure S3C).
Importantly for our subsequent experimentation below, we
note that all of the cyclins E and A are bound by Cdk2 in
both cell types, demonstrating that 50% reduction of Cdk2
protein has no consequences on efficiency of Cdk2–cyclin
complex formation. Treatment of Cdk2+/SN-NeoR clones
with Adenovirus-Cre to remove the NeoR cassette restored
Cdk2 expression to wild type levels (Figure 2E) (Supple-
mentary Figure S4), demonstrating that the introduced
siSN silent point mutations had no detectable consequences
on Cdk2 transcription or translation.
To test our initial hypothesis of selectively regulating
Cdk2 alleles by RNAi, we transfected either control siC-
trl, siWT, siSN or both siWT and siSN into Cdk2+/+
and Cdk2+/SN cells. As expected, Cdk2 protein levels were
highly reduced when siWT was transfected into Cdk2+/+
cells, whereas siSN showed no Cdk2 reduction in Cdk2+/+
cells (Figure 2E) (Supplementary Figure S4). Transfection
of both siWT and siSN into Cdk2+/+ cells was no differ-
ent from siWT alone. However, transfection of siWT into
Cdk2+/SN cells showed only a∼50% reduction of Cdk2 pro-
tein levels (Figure 2E) (Supplementary Figure S4). Like-
wise, transfection of siSN into Cdk2+/SN cells also resulted
in only a ∼50% depletion of Cdk2, whereas transfection of
both siSN and siWT resulted in a complete Cdk2 depletion
in Cdk2+/SN cells. Cdk2 mRNA allele-specific quantitative
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Figure 2. Switching Cdk2 alleles on and off by siRNA. (A) Genomic PCR analysis on clones obtained with control Cdk2-SN rAAV infection alone
showing 2/26 (<8%) recombination events. (B) Genomic PCR analysis on clones obtained with CRISPR-gCdk2 plus Cdk2-SN rAAV with 38/41 (93%)
recombination events. (C) Bar graph of recombination efficiency of combining CRISPR-mediated DNA-cleavage with rAAV-mediated template delivery
analyzed by genomic PCR. (D) Allele-specific sequencing results of wild type allele and recombined Cdk2-SN allele. Bold letters indicate siWT or siSN
siRNA target sites; red letters indicate seven silent mutations of siSN sequence. (E) Cdk2 immunoblot analysis of Cdk2+/+ and Cdk2+/SN cells transfected
with control siCtrl, siWT, siSN or both, as indicated. (F) Bar graph of allele-specific quantitative real-time PCR to detect either WTmRNA or SNmRNA
of Cdk2 in RNAi treated Cdk2+/SN cells, as indicated. Data is from three independent experiments; error bars represent standard deviation.
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Figure 3. Allele specific RNAi depletion between Cdk2-WT and Cdk2-T160A genotypes. (A) Genomic PCR analysis on clones obtained with control
Cdk2-SN-T160A rAAV infection alone showing 1/19 (5%) recombination events. (B) Genomic PCR analysis on clones obtained with CRISPR-gCdk2 plus
Cdk2-SN-T160A rAAVwith 44/48 (92%) recombination events. (C) Bar graph of recombination efficiency of combiningCRISPR-mediatedDNA-cleavage
with rAAV-mediated template delivery analyzed by genomic PCR. (D) Allele-specific sequencing results of wild type allele and recombined Cdk2-T160A
allele. (E) Cdk2 immunoblot analysis of Cdk2+/SN and Cdk2+/SN-T160A cells transfected with control siCtrl, siWT, siSN or both, as indicated. The location
of the T160-PO4 Cdk2 protein is indicated. (F) Propidium iodide DNA flow cytometry cell cycle analysis of Cdk2+/SN-T160A cells transfected with either
siSN, which depletes Cdk2-T160A and expresses wild type Cdk2 (no phenotype), or siWT, which depletes wild type Cdk2 and expresses Cdk2-T160A,
resulting in a cell cycle arrest phenotype. Data is from three independent experiments; error bars represent standard deviation.
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RT-PCR revealed that siWT selectively targeted the wild
type Cdk2WT mRNA, while siSN only targeted the Cdk2SN
mRNA (Figure 2F). These observations demonstrate the
ability of CRISPR plus rAAV to efficiently knockin allele
selective RNAi sequences into cells.
To investigate gene function at endogenous gene ex-
pression and regulation levels using CRISPR plus rAAV,
we introduced an Ala mutation into Cdk2′s activating T-
loop phosphorylation site (T160A) in exon 4 and placed
the siSN sequence in exon 2 (Figure 1B and C). Based
on locus and integration-specific PCR, infection of RPE
cells with only Cdk2-SN-T160A-NeoR rAAV (no CRIPSR)
resulted in 1/19 (5%) NeoR colonies containing recom-
bined Cdk2-SN-T160A single alleles, and no double alle-
les (Figure 3A) (Supplementary Figure S2I). In contrast,
infection of Cdk2-SN-T160A-NeoR rAAV plus transfec-
tion of pX330 CRISPR/Cas9-gCdk2 plasmid resulted in
an impressive 44/48 (92%) NeoR colonies containing re-
combined Cdk2-SN-T160A (Figure 3B). Of the 44 Cdk2-
SN-T160A colonies, 41 (93%) were single Cdk2-SN-T160A
alleles (Cdk2+/SN-T160A) and 3 (7%) were double alleles
(Cdk2SN-T160A/SN-T160A) (Figure 3C) (Supplementary Fig-
ure S2J). We sequenced 4 clones chosen at random and
all four contained both the siSN sequence and the T160A
mutation (Figure 3D). Similarly to the Cdk2 results, re-
combination of the Cdk1 gene with Cdk1-SN-T161E-
NeoR rAAV plus CRISPR/Cas9-gCdk1 plasmid resulted
in 100% recombined clones (40/40) (Supplementary Fig-
ure S5). However, we note that unlike Cdk2 where Cdk1
can partially compensate for complete loss of Cdk2 in
Cdk2SN-T160A/SN-T160A clones, Cdk2 cannot compensate for
Cdk1 loss and we found no double Cdk1SN-T161E/SN-T161E
clones. Transfection of either control siCtrl, siWT, siSN
or both siWT and siSN into control Cdk2+/SN resulted in
allelic-specific depletion of Cdk2 (Figure 3E). Transfection
of siWT into Cdk2+/SN-T160A cells resulted in loss of the
wild type, active Cdk2 T160 phosphorylated version (Fig-
ure 3E), which was accompanied by a characteristic pheno-
typic cell cycle arrest (Figure 3F), with retention of the in-
active Cdk2SN-T160A allele. In contrast, transfection of siSN,
resulted in the selective loss of the Cdk2SN-T160A allele with
continued expression of the wild type Cdk2 allele and had
no effect on cell cycle progression or Cdk2T160 phosphory-
lation. Taken together, these observations demonstrate the
ability of CRISPR plus rAAV to efficiently recombine a ge-
nomic locus and tag it with a selective siRNA sequence that
allows for allele-selective phenotypic assays with the gene of
interest expressed and regulated under endogenous condi-
tions.
DISCUSSION
Although recent studies have demonstrated the utility of
rAAV to deliver CRISPR–Cas9 components (17–20), none
of these studies have used rAAV with CRISPR–Cas9 for
targeted gene replacement into the endogenous locus. Here,
we designed a highly efficient CRISPR-Cas9 and rAAV
targeted gene recombination method to study mammalian
gene function by simultaneously introducing phenotypic
mutations plus selective siRNA sites into one allele of a gene
allowing for expression of a wild type and mutated protein
in the same cell. Identifying silent point mutations to gen-
erate siSN sequences can be readily performed by transfec-
tion of the corresponding expression plasmid and screen-
ing siRNA sequences. Combining rAAV with allele-specific
siRNAs allows for the selective study of haplo-insufficiency
(for siSN) and mutations (for siWT) that are expressed and
regulated under endogenous conditions within the same ge-
netic background. Importantly, a recent single-cell RNA-
Seq study determined that 76–88% of all human autoso-
mal genes are biallelic (expressed from both alleles) and
only 12–24% were mono allelic (21). This suggests that our
CRISPR–Cas9 and rAAV approach should be applicable
to an overwhelmingly large number of genes in the human
genome.
The ease in generating a specific ‘on-target’ DNA dou-
ble strand break by applying the CRISPR–Cas9 technology
has raised multiple questions as to how to identify poten-
tial ‘off-target’ events. Currently, two methods find general
approval: (i) using published ‘off-target’-prediction tools
to identify the top five hits followed by conventional se-
quencing. Surveyor or T7EI assay (7,22–26). Additionally,
(ii) although costly, whole genome deep-sequencing is also
applied. These methods, however, favor the identification
of sequence-related and not phenotype-based ‘off-target’
effects. Combining CRISPR–Cas9 and rAAV with allele-
specific RNAi closes this gap. More specifically, if a phe-
notypic ‘off-target’ event occurred, the phenotype should
be prominent regardless of whether the wild-type or mu-
tated allele is silenced. Hence, our method provides the nec-
essary confidence in the resultant cell line and true siRNA-
mediated phenotype for subsequent functional studies of
the engineered gene.
Collectively, we believe that our CRISPR plus rAAV ap-
proach has broad applicability for studying endogenous
gene function that greatly overcomes the problems associ-
ated with classical gene rescue approaches.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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